|
|
|
|
|
22.12.25 - 11:48
|
Charles Li halts Hong Kong IPO plan for Micro Connect fund under HKEX Chapter 21 (SCMP)
|
|
|
Charles Li Xiaojia, former CEO of Hong Kong Exchanges and Clearing (HKEX), has suspended the initial public offering (IPO) plan of his investment company Micro Connect International Finance (MCIF), according to a letter sent to shareholders.
“This decision stems from our recent recognition that the extended timeline associated with a proposed public listing has begun to outweigh its anticipated benefits, causing delays to MCIF's deployment schedule and impacting Micro Connect's broader......
|
|
|
|
|
22.12.25 - 05:45
|
Hong Kong chip frenzy enters AI lane with Iluvatar IPO (Bamboo Works)
|
|
|
The maker of general purpose GPUs used in AI computing has made its first public filing and passed its listing hearing for a Hong Kong IPO that could raise around $300 million Key Takeaways: By Hugh Chen Call it microchip mania or a silicon feeding frenzy. Whatever you name it, China's AI chip sector.....
The post Hong Kong chip frenzy enters AI lane with Iluvatar IPO appeared first on Bamboo Works....
|
|
|
22.12.25 - 05:36
|
Chinese AI chipmaker Biren kicks off bookbuilding for US$624 million Hong Kong IPO (SCMP)
|
|
|
Shanghai Biren Technology has started bookbuilding for its Hong Kong initial public offering (IPO), aiming to raise up to HK$4.85 billion (US$624 million), as Chinese chipmakers rush to list amid rising investor interest.
Biren, the mainland's first graphics processing unit (GPU) developer to go public in Hong Kong, will start trading on January 2 – becoming the first new listing of 2026. The firm was offering 247.7 million shares between HK$17 and HK$19.60 each, according to its exchange filing......
|
|
|
|
|
|
|
|
|
22.12.25 - 01:45
|
BRIEF: Leading RNA drug developer Ribo passes Hong Kong listing hearing, kicking off IPO (Bamboo Works)
|
|
|
Leading RNA drug developer Suzhou Ribo Life Science Co. Ltd. passed its hearing for a listing on the Hong Kong Stock Exchange, marking the official launch of its IPO, according to its post-hearing information pack released on Sunday on the exchange's website. According to its latest prospectus, Ribo's revenue rose 56.6% to 103.8 million yuan.....
The post BRIEF: Leading RNA drug developer Ribo passes Hong Kong listing hearing, kicking off IPO appeared first on Bamboo Works....
|
|
|
|
|
|
|
|
|
|
|
21.12.25 - 03:24
|
EPW India collects Rs 9 crore from anchor investors; SME IPO to open Monday (Times of India)
|
|
|
EPW India, an IT electronics refurbishing firm, has secured Rs 9.04 crore from anchor investors ahead of its Rs 31.8 crore IPO, opening December 22. The company plans to use the funds for working capital, debt repayment, and general corporate needs. Incorporated in 2021, EPW India specializes in e-waste management and aims for growth on the NSE Emerge platform....
|
|
|
|
|
|
|
|
|
|
|
|
|
|